Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Wyatt
Canadian Public Reimbursement of Biosimilars (Referred to as Subsequent Entry Biologics – Sebs – In Canada), an Update
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Biologics in Uveitis: An Update
Indian Journal of Inflammation Research
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology
Journal of the Advanced Practitioner in Oncology
An American-Canadian Neurologist Returns to Canada
Canadian Journal of Neurological Sciences
Medicine
Neurology
An American-Canadian Neurologist Returns to Canada
Canadian Journal of Neurological Sciences
Medicine
Neurology
An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcp21 - Biosimilars in the Uk – A 2018 Update
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
The Impact of the Entry of Biosimilars: Evidence From Europe
Review of Industrial Organization
Management
Economics
Organizational Behavior
Human Resource Management
Strategy
Innovation
Management of Technology
Econometrics
